Suppr超能文献

基于肿瘤大小和位置的易于使用的系统对甲状腺微小乳头状癌进行风险分层:临床与病理相关性。

Risk stratification of papillary thyroid microcarcinomas via an easy-to-use system based on tumor size and location: clinical and pathological correlations.

机构信息

Department of Histology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş, Romania;

出版信息

Rom J Morphol Embryol. 2020 Oct-Dec;61(4):1153-1162. doi: 10.47162/RJME.61.4.17.

Abstract

INTRODUCTION

We aimed to determine whether two clinically accessible parameters, tumor size and location within the thyroid, correlate with clinicopathological features that are predictors of high risk in papillary thyroid microcarcinomas (PTMCs).

MATERIALS AND METHODS

PTMC cases were obtained from the database of the Department of Pathology, Emergency County Hospital, Târgu Mureş, Romania. Four tumor groups were created based on tumor size and location: Group I (≥5 mm, subcapsular), Group II (≥5 mm, nonsubcapsular), Group III (<5 mm, subcapsular), and Group IV (<5 mm, nonsubcapsular) PTMCs. Clinicopathological features and follow-up data were compared by univariate and multivariate analysis.

RESULTS

Our study included 164 PTMCs (n=70/20/19/55 in Groups I∕II∕III∕IV, respectively). High-grade morphological features, such as plump pink cells (p=0.010), tumor desmoplasia (p=0.022) and sclerosis (p=0.001), infiltrative tumor borders (p=0.005), positive resection margins (p=0.005), invasion into the perithyroid adipose tissue (p=0.001), irregular nuclear membranes (p=0.004), and pseudoinclusions (p=0.001) were significantly more prevalent among Group I PTMCs. Group IV PTMCs were characterized by a paucity of the above-mentioned morphological features, while Group II and III PTMCs displayed intermediate morphological profiles.

CONCLUSIONS

Group I PTMCs proved to be associated with more aggressive morphological features and might need a more careful clinical approach.

摘要

介绍

我们旨在确定两个临床可及的参数,肿瘤大小和甲状腺内位置,是否与预测甲状腺微小乳头状癌(PTMC)高危的临床病理特征相关。

材料与方法

PTMC 病例取自罗马尼亚特尔古穆列什急救县医院病理科数据库。根据肿瘤大小和位置将肿瘤分为四组:I 组(≥5mm,包膜下)、II 组(≥5mm,非包膜下)、III 组(<5mm,包膜下)和 IV 组(<5mm,非包膜下)。通过单因素和多因素分析比较临床病理特征和随访数据。

结果

本研究共纳入 164 例 PTMC(n=70/20/19/55 分别在 I∕II∕III∕IV 组)。高分级形态特征,如饱满的粉红色细胞(p=0.010)、肿瘤性纤维组织增生(p=0.022)和硬化(p=0.001)、浸润性肿瘤边界(p=0.005)、阳性切缘(p=0.005)、侵犯甲状腺周围脂肪组织(p=0.001)、不规则核膜(p=0.004)和假包涵体(p=0.001)在 I 组 PTMC 中更为常见。IV 组 PTMC 的特征是缺乏上述形态特征,而 II 组和 III 组 PTMC 则表现出中间形态特征。

结论

I 组 PTMC 与侵袭性更强的形态特征相关,可能需要更仔细的临床处理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ef/8343526/59065d8aaa70/RJME-61-4-1153-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验